Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
Fresenius Medical Care AG & Co. KGaA / Key word(s): Strategic Company Decision
Bad Homburg, 21 February 2023. The Supervisory Board of Fresenius Medical Care Management AG has today approved the Management Board’s resolution to initiate firm plans for a change of the legal form of Fresenius Medical Care AG & Co. KGaA (the "Company") from a partnership limited by shares (Kommanditgesellgesellschaft auf Aktien – KGaA) into a German stock corporation (Aktiengesellschaft – AG). The Supervisory Board of Fresenius Medical Care AG & Co. KGaA has taken note with approval of the resolutions mentioned before. It is intended to convene an extraordinary general meeting of the Company at the beginning of the third quarter 2023 which shall resolve on the change of the legal form. Thereby, the Management Board and the Supervisory Board of Fresenius Medical Care Management AG as well as the Supervisory Board of Fresenius Medical Care AG & Co. KGaA support the intention of Fresenius SE & Co. KGaA to seek the deconsolidation of the Company.
21-Feb-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Fresenius Medical Care AG & Co. KGaA
61352 Bad Homburg
+49 (0) 6172- 609 2525
+49 (0) 6172- 609 2301
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE, Luxembourg Stock Exchange
EQS News ID:
End of Announcement
EQS News Service